Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
ST Huluwa: Subsidiary Guangxi Weiwei Pharmaceutical Co., Ltd. obtains the drug registration certificate for Ambroxol Hydrochloride Drops
ST Huluwa Announcement: Our wholly-owned subsidiary, Guangxi Weiwei Pharmaceutical Co., Ltd., recently received the “Drug Registration Certificate” issued by the National Medical Products Administration for Ambroxol Hydrochloride Drops. Ambroxol Hydrochloride Drops are used for thick and difficult-to-expectorate sputum. The approved medication has been reviewed and approved based on technical requirements that ensure quality and efficacy consistent with the reference product. After approval, it is considered to have passed the consistency evaluation for generic drugs in terms of quality and efficacy.